Recent developments with live-attenuated recombinant paramyxovirus vaccines

Reviews in Medical Virology
Jean-Christophe Le BayonG Boivin

Abstract

There is no vaccine currently approved for paramyxovirus-induced respiratory diseases in humans, despite their major clinical importance. We review the development and evaluation of new vaccine strategies based on live-attenuated chimeric and recombinant vaccines against human respiratory syncytial virus, human metapneumovirus and human parainfluenza viruses types 1 to 3, which are significant causes of upper and lower tract respiratory diseases. Most promising strategies are based on virus attenuation through (i) mutations in key genes involved in replication; (ii) deletion of accessory genes; or (iii) the use of a corresponding animal viral vector, such as bovine parainfluenza type 3 and Sendai virus, as a background for the expression of a viral glycoprotein. Indeed, the fusion (F), or attachment (HN/H/G) glycoproteins are the most immunogenic antigens in paramyxoviruses. For each strategy, we will review the immunogenicity (increase in neutralising antibody titres) and the protection conferred by the most promising recombinant vectored vaccines and list ongoing clinical trials. We will conclude by discussing the most important challenges regarding the introduction of such vaccines into immunisation programmes.

References

Jan 1, 1986·American Journal of Diseases of Children·R C WelliverN McCarthy
Jun 1, 1986·American Journal of Diseases of Children·W P GlezenJ A Kasel
Dec 1, 1966·Proceedings of the Society for Experimental Biology and Medicine·E B Buynak, M R Hilleman
Mar 24, 1969·JAMA : the Journal of the American Medical Association·E B BuynakM R Hilleman
Feb 2, 1967·The New England Journal of Medicine·M R HillemanJ E Whitman
Dec 1, 1984·The Journal of Infectious Diseases·W P GlezenJ A Kasel
Jan 1, 1980·The Journal of Infectious Diseases·C B HallJ M Geiman
May 1, 1994·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·K J HenricksonL L Savatski
Feb 17, 1998·European Journal of Immunology·T HussellP J Openshaw
Aug 5, 1999·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·A MarxL J Anderson
Sep 29, 1999·Proceedings of the National Academy of Sciences of the United States of America·A Bermingham, P L Collins
Nov 30, 2000·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·S ChakrabartiD W Milligan
Oct 6, 2001·Vaccine·P J OpenshawW Olszewska
Jan 9, 2003·JAMA : the Journal of the American Medical Association·William W ThompsonKeiji Fukuda

❮ Previous
Next ❯

Citations

Dec 10, 2015·Expert Review of Vaccines·Charles J Russell, Julia L Hurwitz
Nov 11, 2014·Expert Review of Vaccines·Mark A Mogler, Kurt I Kamrud
Apr 24, 2018·Journal of Investigative Medicine : the Official Publication of the American Federation for Clinical Research·Dima Dandachi, Maria C Rodriguez-Barradas
Apr 1, 2014·Expert Review of Anti-infective Therapy·Paola MarchisioNicola Principi
Jul 28, 2012·Reviews in Medical Virology·Pd Griffiths
Dec 9, 2016·Glycoconjugate Journal·Cassandra L PeggJeffrey J Gorman

❮ Previous
Next ❯